PK Biosciences Corporation  founded in 2006 is a privately held startup Biotechnology Company located in Midwest USA. It is an innovative company focused on developing research and diagnostic tools for drug discovery and therapeutic development for treatment of cancer, neurological and neurodegenerative diseases.

Our technology tools specifically target cell signaling molecules involved in apoptotic cell death.  Since inception in 2006, we have achieved important milestone and strengthened our expertise and scientific capabilities.

As a development-stage company PK Biosciences Corporation value its success on partnership, collaboration and equity investment from pharmaceutical industries and venture capital investment.

We are continually looking for business partners/collaborators/ investors who can see the true long-term value of investment in this company.

Potential investors should contact the President of our company

Dr. Anumantha G Kanthasamy, at kant@pkbio.com.